TITLE:
ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

CONDITION:
Prostate Cancer

INTERVENTION:
ZD4054 15 mg

SUMMARY:

      This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating
      prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo
      (sugar pill). The study will also provide further information on the safety of ZD4054
      (Zibotentan).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Surgically or medically castrated

          -  Bone metastasis

          -  Rising PSA

        Exclusion Criteria:

          -  Opiate use

          -  Prior chemotherapy
      
